FAM
AMGN icon

Fairtree Asset Management’s Amgen AMGN Stock Holding History

Fairtree Asset Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,763
Closed -$2.87M – 97
2025
Q4 		$2.87M Buy
+8,763
New +$2.78M 1.32% 23
2025
Q1 		– Sell
-2,250
Closed -$586K – 105
2024
Q4 		$586K Buy
+2,250
New +$668K 0.56% 54

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fairtree Asset Management's AMGN Position: Q1 2026 in Review

Fairtree Asset Management sold out of Amgen (AMGN) in Q1 2026, closing a stake of 8,763 shares — an estimated $2.87M sold.

Fairtree Asset Management first reported a position in AMGN in Q4 2024 and held it in 2 quarters. The position peaked at $2.87M in Q4 2025. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Fairtree Asset Management reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Fairtree Asset Management sold 8,763 Amgen shares in Q1 2026, an estimated $2.87M.
  • Fairtree Asset Management first reported a position in Amgen in Q4 2024 and held it in 2 quarters.
  • Fairtree Asset Management's Amgen position peaked at $2.87M in Q4 2025.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Fairtree Asset Management's 13F filing for Q1 2026, filed 13 May 2026.